Dr Lal Pathlabs Q4 Results- 52 week Low
Shares of Dr Lal Pathlabs hit 52-week low of Rs 2,047.70 and slipped 6 per cent on the BSE in Wednesday’s intra-day trade.
The decline comes after the company posted 14 percent dip year on year (YoY) in profit after tax (PAT) to Rs 72.9 in March.
Dr Lal Pathlabs Q4 Results- 40% Dip in Profit
Dr Lal Pathlabs Q4 Results- Leading Diagnostic
The company, a leading diagnostic provider, had posted profit of Rs 85.1 crore in the same quarter last fiscal.
The stock breached its previous low of Rs 2,151.05 that it had touched on Monday, May 16, 2022.
Dr Lal Pathlabs Q4 Results- Previous Low
Dr Lal Pathlabs Q4 Results- Declined
In the past one month, Dr Lal Pathlabs stock declined 23 per cent, as compared to 6 per cent fall in the S&P BSE Sensex.
Dr Lal Pathlabs operating revenue increased by 12.7 percent YoY in Q4 to Rs 485.5 crore from Rs 431.0 crore, a year ago
Dr Lal Pathlabs Q4 Results- Revenue
Dr Lal Pathlabs Q4 Results- EBITDA
Dr Lal Pathlabs (EBITDA) margins contracted 630 basis points to 19.4 per cent from 25.7 per cent in Q4FY21
The management said that though Q4FY22 began well, the onset of Omicron wave in the quarter impacted non-COVID business.
Dr Lal Pathlabs Q4 Results- Non Covid Part
Dr Lal Pathlabs Q4 Results- Swipe Up!!!
Swipe up for More Stories related to Tchnology, Gadgets, Finance, & Other Trending News around the Globe.